Jackson Trachette L
University of Michigan, Department of Mathematics, Ann Arbor 48109-1109, USA.
J Math Biol. 2002 Mar;44(3):201-26. doi: 10.1007/s002850100118.
A mathematical model is presented to describe the evolution of a vascular tumor in response to traditional chemotherapeutic treatment. Particular attention is paid to the effects of a dynamic vascular support system in a tumor comprised of competing cell populations that differ in proliferation rates and drug susceptibility. The model consists of a system of partial differential equations governing intratumoral drug concentration, cancer cell density, and blood vessel density. The balance between cell proliferation and death along with vessel production and destruction within the tumor generates a velocity field which drives the expansion or regression of the neoplasm. Radially symmetric solutions are obtained for the case when only one cell type is present and when the proportion of the tumor occupied by blood vessels remains constant. The stability of these solutions to asymmetric perturbations and to a small semi-drug resistant cell population is then investigated. The analysis shows that drug concentrations which are sufficient to insure eradication of a spherical tumor may be inadequate for the successful treatment of non-spherical tumors. When the drug is continuously infused, linear analysis predicts that whether or not a cure is possible is crucially dependent on the proliferation rate of the semi-resistant cells and on the competitive effect of the sensitive cells on the resistant population. When the blood vessel density is allowed to change dynamically, the model predicts a dramatic increase in the tumor's growth and decrease in its response to therapy.
提出了一个数学模型来描述血管肿瘤在传统化疗治疗下的演变。特别关注了动态血管支持系统在由增殖率和药物敏感性不同的竞争性细胞群体组成的肿瘤中的作用。该模型由一组偏微分方程组成,用于控制肿瘤内药物浓度、癌细胞密度和血管密度。肿瘤内细胞增殖与死亡以及血管生成与破坏之间的平衡产生了一个速度场,该速度场驱动肿瘤的扩张或消退。对于仅存在一种细胞类型且肿瘤中血管所占比例保持恒定的情况,得到了径向对称解。然后研究了这些解对非对称扰动和少量半耐药细胞群体的稳定性。分析表明,足以确保根除球形肿瘤的药物浓度可能不足以成功治疗非球形肿瘤。当持续输注药物时,线性分析预测治愈是否可能关键取决于半耐药细胞的增殖率以及敏感细胞对耐药群体的竞争效应。当允许血管密度动态变化时,该模型预测肿瘤生长会显著增加,对治疗的反应会降低。